Treatment successfully delivers drug across the blood-brain barrier directly to brain tumor in mice
- Glioblastoma currently has no cure. New treatments urgently needed
- Powerful drug is 1,400 times more potent than current treatment against the brain tumor
- Scientists applying to FDA for approval to test this novel treatment in patients with recurrent glioblastoma
One of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can’t be used in patients because of two problems. First, it can’t reach its target because it’s blocked by the blood-brain barrier, a microscopic structure that protects the brain from toxins in the blood. And the conventional formulation for this drug is toxic to the brain.
But now Northwestern Medicine scientists have used a novel technology for opening the blood-brain barrier with an implantable ultrasound, and have delivered the powerful drug to the tumor in mice. In a new paper, they report on their findings of extensive preclinical research.
The scientists also discovered brain toxicity for the conventional formulation for this drug – paclitaxel -to the brain was caused by the solution required to dissolve the drug (cremophor.) Scientists tested a new formulation of the drug that uses albumin as opposed to cremophor, and it was not harmful to the brain.
Opening of the blood-brain barrier with an ultrasound increased the concentrations of this paclitaxel in the brain by five-fold. The study also showed that the brain tumor-bearing mice live much longer when treated with the powerful cancer-fighting drug paclitaxel, and survival was even further extended when treated in combination with ultrasound to open the blood-brain barrier.
The study will be published Dec. 12 in Clinical Cancer Research, a journal of the American Association for Cancer Research.
In the laboratory, paclitaxel is much more potent than the currently used chemotherapy temozolomide. When paclitaxel was tested against the brain tumor in a dish outside an organism, a 1,400-fold lesser drug concentration was necessary to kill same number of tumor cells, compared to the conventional chemotherapy used for this cancer.
The scientists are now applying to the U.S. Food & Drug Administration to launch a clinical trial to test this concept of a new formulation of paclitaxel in combination with the novel ultrasound technology to open the blood-brain barrier in patients. The planned trial aims to determine if the treatment is safe, and if it prolongs survival of patients with brain cancer.
“Glioblastoma currently has no cure, and when the tumor recurs there are not many treatment options,” said the principal investigator for this study, Dr. Adam Sonabend, an assistant professor of neurological surgery at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician. “We urgently need effective new treatments.”
The ultrasound technology may have broader benefits. “This ultrasound technology now will enable us to use many agents established in other cancers for patients with brain tumors,” said co-investigator Roger Stupp, chief of neuro-oncology and the Paul C. Bucy Professor of Neurological Surgery at Feinberg.
Other clinical trials are testing ultrasound-based opening of the blood brain barrier with various chemotherapy agents, but none are using such a potent drug as paclitaxel.
How does it work?
The tiny ultrasound would be implanted during surgery into a window in the skull that does not contain bone. It is used in combination with microscopic gas bubbles injected into the blood at the same time the ultrasound begins. When the bubbles hit the sound waves, these vibrate and mechanically disrupt the blood-brain barrier. The opening is immediate, allowing penetration of the drug molecules. The blood-brain barrier opening is reversible and lasts for several hours after the sonication. The ultrasound emitter remains in the skull for repeated delivery of the drug.
Go deeper with Bing News on:
- Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signalingon March 5, 2021 at 1:54 am
Ciclopirox (CPX) is an antifungal drug that has recently been reported to act as a potential anticancer drug. However, the effects and underlying molecular mechanisms of CPX on glioblastoma multiforme ...
- Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR–STAT3 signallingon March 4, 2021 at 2:22 pm
Gao et al. show that a secretory variant of E-cadherin encoded by a circular RNA directly activates EGFR and STAT3 signalling, thereby promoting glioma stem cell tumorigenicity.
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastomaon March 3, 2021 at 4:00 pm
Finally, we show that established glioblastoma subtype classifiers are variably expressed across individual cells within a tumor and demonstrate the potential prognostic implications of such ...
- Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cellson March 3, 2021 at 4:00 pm
These authors contributed equally to this work. See allHide authors and affiliations Glioblastoma (GBM) is the most aggressive brain cancer in adults. GBM stem cells (GSCs) contribute to tumor ...
- The COVID Vaccine Made History. Let's Channel That Energy Into Curing Cancers Like Mineon March 2, 2021 at 1:49 pm
A biopsy would later confirm what the doctors already suspected: It was cancer—specifically glioblastoma, the most aggressive form of brain cancer that stole the lives of Beau Biden, John McCain ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Automated Breast Ultrasound System Market Size, Share & Trends Analysis Report With Growth Forecast 2020-2027on March 8, 2021 at 8:52 am
Global Automated Breast Ultrasound System market is segregated on the basis of Product type as automated breast ...
- Maine Knights purchase ultrasound machines for pregnancy centers in Brunswick and Rocklandon March 8, 2021 at 7:07 am
Pregnancy centers in Brunswick and Rockland now have new, state-of-the-art ultrasound machines thanks to the generosity of Knights of ...
- Veterinary Ultrasound Scanners Market 2021: Increasing Demand for Efficient Management Practices Report Till 2028on March 8, 2021 at 4:44 am
In terms of revenue, the global veterinary ultrasound scanners market is expected to register a CAGR of 4.2% during the forecast period, 2018-2028. The primary objective of the report is to offer ...
- Ultrasound elastography do not show the actual status of postoperative liver fibrosison March 7, 2021 at 10:14 pm
It is well-known that patients who undergo Fontan surgery slowly develop liver fibrosis for years post-operatively. In the past decade, these incidences have been steadily increasing and this is due ...
- NE-YO and Wife Crystal Smith Share Ultrasound Video of Their Baby on the Wayon March 4, 2021 at 9:42 pm
NE-YO's wife Crystal Smith shared a video taken during an ultrasound of the couple's little one on the way. She captioned her post with a white heart. Get push notifications with news, features and ...